Migraine trials in India
3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleA Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
- Where
- Bangalore, Gurugram, Kolkata, Mangalore, Nashik, Thane, Visakhapatnam
- Age
- 18 years and over
- People
- 60
- Run by
- Pfizer
See details and how to joinNCT07685769 - Phase 3Not yet taking people in IndiaEFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR CORTEX ON HEADACHE FREQUENCY IN PATIENTS WITH CHRONIC MIGRAINE
- Where
- New Delhi
- Age
- 18 years to 60 years
- People
- 32
- Run by
- Dr. Ram Manohar Lohia Hospital
See details and how to joinNCT07743814 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Ahmedabad, Ajmer, Guntur, Lucknow, Mangaluru, Mumbai, Nagpur, Nashik
- Age
- 18 years to 45 years
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00